Literature DB >> 24821101

The pathophysiology of thyroid eye disease.

Shannon J C Shan1, Raymond S Douglas.   

Abstract

The pathophysiology of thyroid eye disease (TED) is complex and incompletely understood. Orbital fibroblasts (OFs) seem to be the key effector cells that are responsible for the characteristic soft tissue enlargement seen in TED. They express potentially pathogenic autoantigens, such as thyrotropin receptor and insulin-like growth factor-1 receptor. An intricate interplay between these autoantigens and the autoantibodies found in Graves disease may lead to the activation of OFs, which then leads to increased hyaluronan production, proinflammatory cytokine synthesis, and enhanced differentiation into either myofibroblasts or adipocytes. Some of the OFs in TED patients seem to be derived from infiltrating fibrocytes. These cells originate from the bone marrow and exhibit both fibroblast and myeloid phenotype. In the TED orbit, they may mediate the orbital expansion and inflammatory infiltration. Last, lymphocytes and cytokines are intimately involved in the initiation, amplification, and maintenance of the autoimmune process in TED.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821101     DOI: 10.1097/WNO.0000000000000132

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  23 in total

Review 1.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

2.  Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy.

Authors:  Ahmed Ak Abdel Razek; Mohamed El-Hadidy; Mohamed E Moawad; Nader El-Metwaly; Amr A El-Said
Journal:  Neuroradiol J       Date:  2017-04-05

Review 3.  T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.

Authors:  Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

4.  Effect of smoking on retrobulbar blood flow in thyroid eye disease.

Authors:  A Sadeghi-Tari; M Jamshidian-Tehrani; A Nabavi; S Sharif-Kashani; E Elhami; N Hassanpour; K Ameli Zamani
Journal:  Eye (Lond)       Date:  2016-08-19       Impact factor: 3.775

5.  Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.

Authors:  M Riedl; A Kuhn; I Krämer; E Kolbe; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2016-02-17       Impact factor: 4.256

Review 6.  Extracellular matrix and the maintenance and loss of peripheral immune tolerance in autoimmune insulitis.

Authors:  Carlos O Medina; Nadine Nagy; Paul L Bollyky
Journal:  Curr Opin Immunol       Date:  2018-09-22       Impact factor: 7.486

7.  The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment.

Authors:  James T Rosenbaum; Dongseok Choi; Amanda Wong; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant K Parekh; Gerald J Harris; Michael Kazim; Payal J Patel; Valerie A White; Peter J Dolman; Deepak P Edward; Hind M Alkatan; Hailah Al Hussain; Dinesh Selva; R Patrick Yeatts; Bobby S Korn; Don O Kikkawa; Patrick Stauffer; Stephen R Planck
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

8.  TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.

Authors:  Hong Chen; Shannon J C Shan; Tünde Mester; Yi-Hsuan Wei; Raymond S Douglas
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

9.  Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.

Authors:  Kai-Ling Yong; Chiaw Ling Chng; Hla Myint Htoon; Lee Hooi Lim; Lay Leng Seah
Journal:  Int J Endocrinol       Date:  2015-11-22       Impact factor: 3.257

10.  Prognostic factors of restrictive myopathy in thyroid eye disease.

Authors:  Jae Hwan Choi; Hoon Noh; Yoon-Duck Kim; Kyung In Woo
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.